Together, these results predict that the lncRNA_DSCR8-miR-22-3p-ARPC5 axis is a regulating mechanism in the occurrence and development of LC and a potential therapeutic target. The gene discussed is ARPC5; the disease is laryngotracheoesophageal cleft.